Anne H. Cross

Aug 29, 2023 | neurologylive.com | Anne H. Cross

WATCH TIME: 3 minutes“I think we need to understand why neurons die, why axons die, why oligodendroglial don't proliferate, and remyelinate axons when they are demyelinated. We need to understand those processes better and there are scientists that are focused on that right now.

Jun 4, 2023 | neurologylive.com | Anne H. Cross

WATCH TIME: 5 minutesOften impacting patients in their early adulthood, multiple sclerosis (MS) is an immune-mediated disorder that affects the central nervous system in the brain. From disease onset, approximately 10% of patients with MS experience chronic progression.1 Treating patients with progressive forms of the disease has been a challenge, as there is only 1 FDA-approved therapy for this specific patient population.

Feb 2, 2023 | medscape.com | Anne H. Cross |Riley Bove

This transcript has been edited for clarity. Anne Cross, MD: Hello, I am Dr Anne Cross. Welcome to Medscape's InDiscussion series on multiple sclerosis. Women constitute the majority of MS patients, with an approximate 3-to-1 female-to-male ratio in MS, and many MS patients are diagnosed when in their twenties and thirties, which are prime ages for childbirth in women. In addition, these same women will experience hormonal changes over their lifespans, and eventually they'll go through menopause.